Karyopharm(KPTI)

1.02 -0.08 -7.2727%

今开:1.13昨收:1.1
最高:1.2 最低:1.02
涨停价:0.0跌停价:0.0
总市值:1.20064468E8

Karyopharm的热门讨论

持股变动声明

Karyopharm(KPTI)03-05 08:45

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025190  Size: 7 KB 网页链接查看全文

持股变动声明

Karyopharm(KPTI)03-05 08:45

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025188  Size: 7 KB 网页链接查看全文

持股变动声明

Karyopharm(KPTI)03-01 06:45

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-023281  Size: 4 KB 网页链接查看全文

持股变动声明

Karyopharm(KPTI)03-07 05:15

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027153  Size: 5 KB 网页链接查看全文

季度财报

Karyopharm(KPTI)今天 04:15

$Karyopharm(KPTI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-055672  Act: 34  Size: 7 MB 网页链接查看全文

持股变动声明

Karyopharm(KPTI)03-01 06:45

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-023285  Size: 4 KB 网页链接查看全文

持股变动声明

Karyopharm(KPTI)03-01 06:45

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-023297  Size: 4 KB 网页链接查看全文

年度财报

Karyopharm(KPTI)02-29 20:45

$Karyopharm(KPTI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-022650  Act: 34  Size: 16 MB 网页链接查看全文

持股变动声明

Karyopharm(KPTI)03-05 08:45

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025191  Size: 7 KB 网页链接查看全文

其他

Karyopharm(KPTI)04-19 19:45

$Karyopharm(KPTI)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-045718  Act: 34  Size: 1 MB 网页链接查看全文

1 2 3 4

Karyopharm的最新讨论

酒鬼爱花生03-11 12:47

$Karyopharm(KPTI)$ 和德琪医药市值相当,因塞里尼所结缘的两家公司查看全文

LAES16802-06 01:29

$Karyopharm(KPTI)$ 逆市飘扬,传被一家大型公司收购。查看全文

LAES16802-01 08:54

$Karyopharm(KPTI)$ 尾盘1️⃣笔50多万砸给了自己人,盘后又收回。看来要启动了查看全文

转出首个上市产品的部分商业化权利,德琪医药意欲何为?

药智网2023-08-24 15:20

来源:药智网公众号
图片来源:摄图网
近日,港股上市公司德琪医药发布公告称,与翰森制药达成独家合作协议,由翰森制药负责塞利尼索在中国大陆的商业化, 德琪医药将获最高2亿元首付款及最高5.35亿元里程碑付款。
据了解,塞利尼索是德琪医药首个上市商业化产品,从Karyopharm引进,...查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Karyopharm的公告

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-035028  Size: 9 KB 网页链接

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-035030  Size: 5 KB 网页链接

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-035031  Size: 9 KB 网页链接

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-031481  Size: 5 KB 网页链接

$Karyopharm(KPTI)$ 内部交易: 2021-05-06,Director,BOHLIN GAREN G ,买入,4000普通股, $7.82

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-031437  Size: 8 KB 网页链接

$Karyopharm(KPTI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-030166  Size: 11 KB 网页链接

$Karyopharm(KPTI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-21-000073  Act: 34  Size: 7 MB 网页链接

$Karyopharm(KPTI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-21-146627  Act: 34  Size: 266 KB 网页链接

$Karyopharm(KPTI)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-21-146629  Act: 34  Size: 37 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98